Alle Filter zurücksetzen
Kategorien
  • Pharma / Gesundheit
  • Pharmaindustrie / Medikamente
  • Schmerzen / Migräne / Analgetika
  • Filter zurücksetzen
Regionen/Länder
  • Europa
  • Belgien
  • Bosnien-Herzegowina
  • Bulgarien
  • Dänemark
  • Deutschland
  • Estland
  • Finnland
  • Frankreich
  • Griechenland
  • Irland
  • Italien
  • Kroatien
  • Lettland
  • Litauen
  • Mazedonien
  • Niederlande
  • Norwegen
  • Österreich
  • Poland
  • Portugal
  • Rumänien
  • Russian Federation
  • Schweden
  • Schweiz
  • Serbien
  • Slowakei
  • Slowenien
  • Spanien
  • Tschechien
  • Türkei
  • Ukraine
  • Ungarn
  • Vereinigtes Königreich
  • Weißrussland
  • Weißrussland
  • Asien / Pazifik
  • China
  • Hong Kong
  • Indien
  • Indonesien
  • Japan
  • Kasachstan
  • Malaysia
  • Neuseeland
  • Pakistan
  • Philippinen
  • Singapur
  • Südkorea
  • Taiwan
  • Thailand
  • Usbekistan
  • Vietnam
  • Mittlerer Osten / Afrika
  • Ägypten
  • Algerien
  • Iran
  • Israel
  • Kamerun
  • Kenia
  • Marokko
  • Nigeria
  • Saudi Arabien
  • South Africa
  • Tunesien
  • Vereinigte Arabische Emirate
  • Nordamerika / USA
  • Kanada
  • United States
  • Australien
  • Mittel- / Südamerika
  • Argentinien
  • Bolivien
  • Brasilien
  • Chile
  • Costa Rica
  • Kolumbien
  • Mexiko
  • Peru
  • Uruguay
  • Venezuela
  • Filter zurücksetzen
Herausgeber
  • Biopharm Reports
  • Canadean
  • Datamonitor
  • Euromonitor
  • GBI Research
  • Global Markets Direct
  • GlobalData
  • Life Science Analytics
  • Technavio
  • Filter zurücksetzen
Sprache
  • Englisch
  • Filter zurücksetzen
Datum
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • Filter zurücksetzen
laedt

Marktanalyse - Analgesics in Morocco

Euromonitor

Euromonitor

7 / 2012
36 Seiten
Typ: Marktanalyse
Sprache: Englisch
Regionen: Marokko
Verfügbarkeit: verfügbar

Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:

675,00 €*
PDF-Datei per E-Mail , versandkostenfrei


The number of consumers switching to products that are perceived as being safer and as having fewer side effects continued to increase within systemic analgesics during 2011. According to trade sources, an increasing number of consumers are switching from adult aspirin, which has the potential to cause stomach bleeding, to either acetaminophen or combination products. Similarly, there is a shift away from child-specific aspirin towards child-specific ibuprofen. Meanwhile, trade sources...

Euromonitor International's Analgesics in Morocco report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
ANALGESICS IN MOROCCO

Euromonitor International

July 2012



LIST OF CONTENTS AND TABLES



Headlines

Trends

Switches

Competitive Landscape

Prospects

Category Data

Table 1 Sales of Analgesics by Category: Value 2006-2011

Table 2 Sales of Analgesics by Category: % Value Growth 2006-2011

Table 3 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011

Table 4 Analgesics Company Shares by Value 2007-2011

Table 5 Analgesics Brand Shares by Value 2008-2011

Table 6 Forecast Sales of Analgesics by Category: Value 2011-2016

Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Afric-phar SA in Consumer Health (morocco)

Strategic Direction

Key Facts

Summary 1 Afric-Phar SA: Key Facts

Company Background

Production

Competitive Positioning

Summary 2 Afric-Phar SA: Competitive Position 2011

Cooper Maroc in Consumer Health (morocco)

Strategic Direction

Key Facts

Summary 3 Cooper Maroc: Key Facts

Summary 4 Cooper Maroc: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 5 Cooper Maroc: Competitive Position 2011

Laboratoires Laprophan in Consumer Health (morocco)

Strategic Direction

Key Facts

Summary 6 Laboratoires Laprophan: Key Facts

Summary 7 Laboratoires Laprophan: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 8 Laboratoires Laprophan: Competitive Position 2011

Laboratoires Pharma 5 in Consumer Health (morocco)

Strategic Direction

Key Facts

Summary 9 Laboratoires Pharma 5: Key Facts

Summary 10 Laboratoires Pharma 5: Operational Indicators

Company Background

Competitive Positioning

Summary 11 Laboratoires Pharma 5: Competitive Position 2011

Laboratoires Sothema in Consumer Health (morocco)

Strategic Direction

Key Facts

Summary 12 Laboratoires Sothema: Key Facts

Summary 13 Laboratoires Sothema: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 14 Laboratoires Sothema: Competitive Position 2011

Maphar Laboratoires SA in Consumer Health (morocco)

Strategic Direction

Key Facts

Summary 15 Maphar Laboratoires SA: Key Facts

Summary 16 Maphar Laboratoires SA: Operational Indicators

Company Background

Competitive Positioning

Summary 17 Maphar Laboratoires SA: Competitive Position 2011

Promopharm SA in Consumer Health (morocco)

Strategic Direction

Key Facts

Summary 18 Promopharm SA: Key Facts

Summary 19 Promopharm SA: Operational Indicators

Company Background

Competitive Positioning

Summary 20 Promopharm SA: Competitive Position 2011

Executive Summary

Consumer Health Experienced Positive Growth in 2011

Stressful and Hectic Lifestyles Continued To Affect the Health of Moroccans

International Players Took the Lead in Consumer Health

Chemists/pharmacies Remained Key Channel

Awareness of Health and Wellness Supports Growth Over the Forecast Period

Key Trends and Developments

Growth Stagnated Despite Improvements in Economy

the Government Kept A Closer Eye on Consumer Health

the List of Medicines Affected by Price Reduction Expanded in 2011

Consumer Products Associated With Ageing Performed Well

Market Indicators

Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011

Table 9 Life Expectancy at Birth 2006-2011

Market Data

Table 10 Sales of Consumer Health by Category: Value 2006-2011

Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011

Table 12 Consumer Health Company Shares 2007-2011

Table 13 Consumer Health Brand Shares 2008-2011

Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011

Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011

Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016

Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventative Medicine

Switches

Definitions

Sources

Summary 21 Research Sources

*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.

Für Sie protokollierte Studien / Marktanalysen:
  zuletzt angesehene Studien: